The transcription factor Srf regulates hematopoietic stem cell adhesion

Blood

Volumn 116, Issue 22, 2010, Pages 4464-4473

  Ragu, Christine ^a,b   Elain, Gaelle ^a   Mylonas, Elena ^a,b   Ottolenghi, Chris ^c   Cagnard, Nicolas ^c   Daegelen, Dominique ^a,c,d   Passegué, Emmanuelle ^e   Vainchenker, William ^a,b   Bernard, Olivier A ^a,b   Penard Lacronique, Virginie ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d CNRS   (France)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; SERUM RESPONSE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASSAY; BONE MARROW CELL; CELL ADHESION; CELL COUNT; CELL CYCLE; CELL DIFFERENTIATION; CELL INTERACTION; CELL LINEAGE; CELL MIGRATION; CYTOSKELETON; ENGRAFTMENT; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VITRO STUDY; LYMPHOID CELL; MOUSE; NONHUMAN; NULL CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEADY STATE; STEM CELL; THROMBOCYTOPENIA;

EID: 78649478748     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-11-251587     Document Type: Article

References (48)

1. Posern G, Treisman R. Actin' together: serum response factor, its cofactors and the link to signal transduction. Trends Cell Biol. 2006;16(11):588-596.
2. Miano JM, Long X, Fujiwara K. Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus. Am J Physiol Cell Physiol. 2007;Jan 292(1):C70-C81.
3. Arsenian S, Weinhold B, Oelgeschläger M, Rüther U, Nordheim A. Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J. 1998;17(21):6289-6299.
4. Brandt DT, Baarlink C, Kitzing TM, et al. SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta(1)-integrin. Nat Cell Biol. 2009;11(5):557-568.
5. Medjkane S, Perez-Sanchez C, Gaggioli C, Sahai E, Treisman R. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat Cell Biol. 2009;11(3):257-268.
6. Mercher T, Coniat MB, Monni R, et al. Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proc Natl Acad Sci U S A. 2001;98(10):5776-5779.
7. Ma Z, Morris SW, Valentine V, et al. Fusion of two novel genes, RBM15 and MKL1, in the t(1; 22)(p13;q13) of acute megakaryoblastic leukemia. Nat Genet. 2001;28(3):220-221.
8. Miralles F, Posern G, Zaromytidou AI, Treisman R. Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell. 2003;113(3):329-342.
9. Vartiainen MK, Guettler S, Larijani B, Treisman R. Nuclear actin regulates dynamic subcellular localization and activity of the SRF cofactor MAL. Science. 2007;316(5832):1749-1752.
10. Wang Z, Wang DZ, Hockemeyer D, McAnally J, Nordheim A, Olson EN. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature. 2004;428(6979):185-189.
11. Costello PS, Nicolas RH, Watanabe Y, Rosewell I, Treisman R. Ternary complex factor SAP-1 is required for Erk-mediated thymocyte positive selection. Nat Immunol. 2004;5(3):289-298.
12. Ayadi A, Zheng H, Sobieszczuk P, et al. Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1. EMBO J. 2001;20(18):5139-5152.
13. Cesari F, Brecht S, Vintersten K, et al. Mice deficient for the ets transcription factor elk-1 show normal immune responses and mildly impaired neuronal gene activation. Mol Cell Biol. 2004;24(1):294-305.
14. Li J, Zhu X, Chen M, et al. Myocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development. Proc Natl Acad Sci U S A. 2005;102(25):8916-8921.
15. Oh J, Richardson JA, Olson EN. Requirement of myocardin-related transcription factor-B for remodeling of branchial arch arteries and smooth muscle differentiation. Proc Natl Acad Sci U S A. 2005;102(42):15122-15127.
16. Ragu C, Boukour S, Elain G, et al. The serum response factor (SRF)/megakaryocytic acute leukemia (MAL) network participates in megakaryocyte development. Leukemia. 2010;24(6):1227-1230.
17. Cen B, Selvaraj A, Burgess RC, et al. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol Cell Biol. 2003;23(18):6597-6608.
18. Descot A, Rex-Haffner M, Courtois G, et al. OTT-MAL is a deregulated activator of serum response factor-dependent gene expression. Mol Cell Biol. 2008;Oct 28(20):6171-6181.
19. Sawada T, Nishiyama C, Kishi T, et al. Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activity. J Biol Chem. 2008;283(39):26820-26828.
20. Parlakian A, Tuil D, Hamard G, et al. Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality. Mol Cell Biol. 2004;24(12):5281-5289.
21. Kuhn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science. 1995;269(5229):1427-1429.
22. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404(6774):193- 197.
23. Yang L, Bryder D, Adolfsson J, et al. Identification of Lin(-)Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood. 2005;105(7):2717-2723.
24. Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell. 2005;121(7):1109-1121.
25. -/- chimeric mice. Blood. 2006;107(6):2243-2251.
26. Schratt G, Philippar U, Berger J, Schwarz H, Heidenreich O, Nordheim A. Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells. J Cell Biol. 2002;156(4):737-750.
27. Fleige A, Alberti S, Grobe L, et al. Serum response factor contributes selectively to lymphocyte development. J Biol Chem. 2007;282(33):24320-24328.
28. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med. 1996;183(4):1797-1806.
29. Buchwalter G, Gross C, Wasylyk B. Ets ternary complex transcription factors. Gene. 2004;324:1-14.
30. Schratt G, Weinhold B, Lundberg AS, et al. Serum response factor is required for immediate-early gene activation yet is dispensable for proliferation of embryonic stem cells. Mol Cell Biol. 2001;21(8):2933-2943.
31. Sun Q, Chen G, Streb JW, et al. Defining the mammalian CArGome. Genome Res. 2006;16(2):197-207.
32. Franco CA, Mericskay M, Parlakian A, et al. Serum response factor is required for sprouting angiogenesis and vascular integrity. Dev Cell. 2008;15(3):448-461.
33. Koegel H, von Tobel L, Schafer M, et al. Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice. J Clin Invest. 2009;119(4):899-910.
34. Forsberg EC, Prohaska SS, Katzman S, Heffner GC, Stuart JM, Weissman IL. Differential expression of novel potential regulators in hematopoietic stem cells. PLoS Genet. 2005;1(3):e28.
35. Zhong JF, Zhao Y, Sutton S, et al. Gene expression profile of murine long-term reconstituting vs. short-term reconstituting hematopoietic stem cells. Proc Natl Acad Sci U S A. 2005;102(7):2448-2453.
36. Steidl U, Kronenwett R, Rohr UP, et al. Gene expression profiling identifies significant differences between the molecular phenotypes of bone marrow-derived and circulating human CD34+ hematopoietic stem cells. Blood. 2002;99(6):2037-2044.
37. Knoll B, Kretz O, Fiedler C, et al. Serum response factor controls neuronal circuit assembly in the hippocampus. Nat Neurosci. 2006;9(2):195-204.
38. Kirstetter P, Anderson K, Porse BT, Jacobsen SE, Nerlov C. Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block. Nat Immunol. 2006;7(10):1048-1056.
39. Scheller M, Huelsken J, Rosenbauer F, et al. Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation. Nat Immunol. 2006;7(10):1037-1047.
40. Zhang J, Grindley JC, Yin T, et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature. 2006;441(7092):518-522.
41. Yilmaz OH, Valdez R, Theisen BK, et al. PTEN dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature. 2006;441(7092):475-482.
42. Yang L, Wang L, Geiger H, Cancelas JA, Mo J, Zheng Y. Rho GTPase Cdc42 coordinates hematopoietic stem cell quiescence and niche interaction in the bone marrow. Proc Natl Acad Sci U S A. 2007;104(12):5091-5096.
43. van Os R, de Haan G, Dykstra BJ. Hematopoietic stem cell quiescence: yet another role for p53. Cell Stem Cell. 2009;4(1):7-8.
44. Wilson A, Murphy MJ, Oskarsson T, et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev. 2004;18(22):2747-2763.
45. Min IM, Pietramaggiori G, Kim FS, Passegue E, Stevenson KE, Wagers AJ. The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells. Cell Stem Cell. 2008;2(4):380-391.
46. Bungartz G, Stiller S, Bauer M, et al. Adult murine hematopoiesis can proceed without beta1 and beta7 integrins. Blood. 2006;108(6):1857-1864.
47. Horwitz BH, Mizgerd JP, Scott ML, Doerschuk CM. Mechanisms of granulocytosis in the absence of CD18. Blood. 2001;97(6):1578-1583.
48. Gilles L, Bluteau D, Boukour S, et al. MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9. Blood. 2009;114(19):4221-4232.